Science and Health News

Alzheimer's disease progressively degrades a person's memory and cognitive abilities, often resulting in dementia. Amid efforts to find novel treatments for this disease, a recent breakthrough study by scientists from Japan shows that oxytocin―the hormone that we commonly know to induce feelings of love and well-being―can also effectively reverse some of the damage caused by amyloid plaques in the learning and memory center of the brain in an animal model of Alzheimer's.

The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that offers a major advance in the treatment  for diabetes.

Ionic-liquid-based technology delivers RNA therapeutic to locally block psoriasis-associated genes in mice

Previous research has suggested vaccinations may have a protective factor against cognitive decline, but there have been no large, comprehensive studies focused on the influenza (flu) vaccine and Alzheimer’s disease risk, specifically. To address this gap, Albert Amran, a medical student at McGovern Medical School at The University of Texas Health Science Center at Houston, and team, investigated a large American health record dataset (n=9,066).

CAR-T immunotherapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial led by researchers at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine in Houston.

People who inherited a special ion channel from Neandertals experience more pain

Researchers from SEAS and the Milken Institute SPH received a $50,000 COVID-19 Technology Maturation Grant to bring their sensor to market faster.

Erectile dysfunction drugs help destroy misfolded proteins in animal models